MEDRAD's Connect.PACS™ application is a contrast dose-management informatics solution that accurately and consistently documents CT contrast media administered intravenously through the Stellant® CT Power Injection System. Healthcare professionals gain immediate access to the patient’s electronic contrast-injection history to review data which can impact patient outcomes. Benefits include:
Nine of the top-25 drugs reported to most frequently result in medication errors are contrast agents.¹ Though critical to patient care, manual documentation of intravenous CT contrast media, a high-alert medication,² is often inaccurate and inconsistent. In fact, one institution reports retrieval of manually recorded documentation failed one of every five times attempted.
¹Santell JP, Hicks RW, Cousins DD. MEDMARX Data Report: A Chartbook of
2000-2004 Findings from Intensive Care Units and Radiological Services. Rockville,
²http://www.ismp.org/tools/highalertmedications.pdf (accessed 04/19/11)